Navigation Links
AMI in Medical News

HORIZONS AMI trial data will help set guidelines

WASHINGTON, DC OCTOBER 24, 2007 Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent ...

Horizons AMI trial data to be presented at TCT 2007

WASHINGTON, DC OCTOBER 15, 2007 -- The Cardiovascular Research Foundation (CRF) will release results of its landmark research study, HORIZONS AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) at the nineteenth annual Transcatheter Cardiovascular Therapeut...

Isis Reports Strong Financial Results and Highlights for First Quarter of 2009

... and the gain it recognized on the sale of Ibis to ami earlier this year. Accounting rules require Isis ...cial statements as a result of the sale of Ibis to ami in January 2009. Net income from discontinued ope...tatement of Operations. Since the sale of Ibis to ami was a discrete event that occurred in the first qu...

Ethnicity affects timing and access to cardiac care

...nts and clinicians need to be aware of ethnic variation in symptoms," says King. "Patients need to know both the classic and atypical presentations of ami (Acute Myocardial Infarction) and emergency department staff need to recognize them." Alberta Health Services (AHS) recognizes cultural diversity ...

Media Urged to Correct Inaccurate References to 'Swine Flu'

... Organization for Animal Health (OIE), North American Flu is a more accurate description of the virus that has affected people in North America," said ami President J. Patrick Boyle. Boyle referenced an OIE press release issued today which read, "The virus has not been isolated in animals to date. ...

Autism Science Foundation Launches Operations; New Advocacy Group Will Focus on Non-vaccine-related Autism Research

...ncludes Dr. Emanuel DiCicco-Bloom (UMDNJ-Robert Wood Johnson Medical School; past program chair of the International Society for Autism Research); Dr. ami Klin (Yale Child Study Center); Dr. Harold Koplewicz (NYU Child Study Center); Dr. Sharon Humiston (University of Rochester); Dr. Eric London (NYS Ins...

Compirion and Henrico Doctors Hospital Team Up to Improve Quality of Care

...cuity patients and at Core Measures indicators for ami and pneumonia patients. The non-critical patients ...oal and $18,500 in billable volume was gained. For ami patients, a Heart Watch packet that contained p...rials, was developed and implemented along with an ami tackle box that contained key drugs for treatment....

Yale researchers discover mechanism for

...ositions to seek their caregivers, to pay special attention to movements in the environment that are associated with human actions and gestures," said ami Klin, director of the Autism Program at Yale and the Harris Associate Professor of Child Psychology at the Yale Child Study Center. Klin, who cond...

Explaining trends in heart attack

...e study found that over the past 40 years rates of ami diagnosed by ECG decreased by 50%, whereas rates of ami diagnosed exclusively by infarction biomarkers dou... an explanation for the apparently steady national ami rates in the face of improvements in primary preve...

Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008

...cial statements as a result of the sale of Ibis to ami in January 2009. The increase in net loss from di... and the cost to achieve milestones as part of the ami transaction partly offset by the gain recognized f...ransaction with Regulus) $215 million from ami (for its transaction with Ibis) ...

More>>

AMI in Medical Technology

Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine

Data from landmark trial provide important insight for physicians in treating heart attack patients NATICK, Mass., May 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today welcomed the publication of results from the HORIZONS AMI trial in this week's issue of the New...

Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use

Nearly 150,000 PCIs Were Performed on AMI Patients in 2008, According to Millennium Research Group WALTHAM, Mass., Feb. 18 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Interventional Cardiology Devices 2009 report, the use of drug-eluting stents will conti...

HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients

Landmark trial provides new insight for physicians NATICK, Mass. and WASHINGTON, Oct. 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced results from an analysis of the HORIZONS AMI trial. The HORIZONS AMI trial, sponsored by the Cardiovascular ...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... and the gain it recognized on the sale of Ibis to ami earlier this year. Accounting rules require Isis ...cial statements as a result of the sale of Ibis to ami in January 2009. Net income from discontinued ope...tatement of Operations. Since the sale of Ibis to ami was a discrete event that occurred in the first qu...

AMA Foundation Announces Seed Grant Research Recipients

...akagawa, M.D., University of California at San Francisco , San Francisco, Calif. Giang Nguyen, Albany Medical College , Albany, N.Y. ami Raval, M.D., Tufts Medical Center, Boston, Mass. Noah Rodriguez, M.D., Harvard Medical School , Boston, Mass. Ming-Sing Si, M.D., Un...

Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008

... issue a press release at this time. -- HORIZONS ami data. At 11:00 a.m., Gregg W. Stone, M.D., will pr...ardial Infarction" in the Main Arena. The HORIZONS ami trial is a randomized, controlled clinical trial d...compare TAXUS stents to bare-metal stents in 3,400 ami (acute myocardial infarction) patients. The Compan...

Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy

... use of human cells in preclinical studies. These results are indicative of cardiomyocyte regeneration and suggest that the injection of ADSCs after ami may have the potential to help the infarcted heart return to normal function. "The study data suggest that injection of adipose-derived stem cells d...

CellCyte Genetics Signs Collaborative Agreement With Northwestern University's Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCyte's CCG-TH30 Product Candidate

... candidate. The goal of the study is to evaluate the functional benefit of the CCG-TH30 therapy in a disease model outcome study representative of the ami (heart attack) indication. Douglas W. Losordo, M.D., a leader in cardiovascular cell therapy research and Director of Feinberg Cardiovascular Research...

Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents

...rly stent thrombosis rate of 1.7% and no reported thrombotic events from one to six months. As part of an extended registry study, 321 patients with ami were followed for one year. Even with the larger patient group, the MACE rate was 13.1% at one year with no mortality beyond the first month. The earl...

Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008

... Other Data Presentations to Focus on Use of Pro-Healing Stent with ami Patients and Those Who Cannot Tolerate Dual-Antiplatelet Therapy HONG KONG, May 8 /PRNewswire/ -- Twelve-month follow-up data from both a randomi...

More>>

AMI in Biological Technology

Seambiotic USA and NASA Glenn Research Center Signed Agreement for Large Scale Microalgae Process Optimization

...pace Act Agreement, NASA is partnering with Seambiotic USA to model growth processes for microalgae for use as aviation biofuel feedstock," said Prof. ami Ben-Amotz, Chief Scientific Adviser to Seambiotic. "The goal of the Agreement is to make use of NASA's expertise in large scale computational modeling...

OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients

...ient (0.2%) having a stent thrombosis. Suryapranata commented, "This rate is impressively low given the highly thrombotic environment associated with ami patients." Longer term follow up is ongoing. Juan F Granada, MD, medical director of the Skirball Center for Cardiovascular Research at Columbi...

Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session

...s completed Phase I clinical trials demonstrating feasibility, safety and biologic activity at a threshold dose. This is the first stem cell trial in ami ever conducted that has prospectively established a significant relationship between dose and effect. Amorcyte has partnered with Progenitor Cell The...

BioComp Pharma Launches First Generic Drug for Tindamax(R)

...oniasis, the intestinal infections giardiasis and intestinal amebiasis and amebic liver abscess. Media Contact: Cohn & Wolfe Ms. ami Shah (212) 537-8048 ami.shah@cohnwolfe.com (1) Saving Money on Prescription Drugs. U.S. Food and Drug Administration. Accessed at:...

LightLab Imaging Leads Global Advancement of Intracoronary Imaging

...htLab by deploying its M2 and M2x OCT imaging systems in critically important clinical studies. All OCT images acquired in the groundbreaking Horizons ami OCT data study, presented at the 2008 American Heart Association Congress, were generated using LightLab Imaging OCT systems. At TCT in October, Ligh...

Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market

...., with an emphasis toward researchers involved in this space. "The ami concept has drawn a phenomenal response, both nationally and internationall...ses researchers' frequently asked questions and provides an overview of the ami selection and creation process." About Alfred Mann Alfred Mann'...

MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008

...oach to Treating Thrombus Containing Lesions (ACS, ami and SVG)" was met with great enthusiasm and excite...t the MGuard(TM) at their local hospitals for ACS, ami and SVG procedures claiming they had many patients...oach to Treating Thrombus Containing Lesions (ACS, ami and SVG)" was a great sensation. The meeting room ...

Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure

...on of renal damage subsequent to cardiac surgery. We expect to initiate a Phase 2b study in patients with heart failure in 2009 and a Phase 2 study in ami patients. About Nile Therapeutics Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the ...

Roche and Response Biomedical Corporation Aim to Reduce 'Vein-to-Brain' Time with New Point-of-Care Cardiac Tests

...ng. Guidelines from the American College of Cardiology and the American Heart Association require or recommend a patient presenting with a potential ami (acute myocardial infarction, or heart attack) be diagnosed within 60 minutes, and preferably within 30 minutes. "One of the advantages of this syst...

Angiotech announces results for the fourth quarter ended December 31, 2007

...") on March 23, 2006. Because of the timing of the ami acquisition, our operating results for the twelve ... rate note refinancing. n. Includes write off of ami tax receivable and write off of certain capit...nization costs related to the integration of ami (849) - Non-recurri...

More>>

Other Tags
(Date:7/11/2014)... -- In people with sex addiction, pornography affects the ... in drug addicts as they consume drugs, a new ... activity between patients who have compulsive sexual behavior and ... study author Dr. Valerie Voon, of the University of ... Voon,s research involved 19 men with sex addiction ...
(Date:7/11/2014)... (HealthDay News) -- U.S. health officials have concluded that ... live anthrax during a safety mishap last month. ... officials have announced a moratorium on the transfer of ... In a report issued Friday, the CDC outlined ... a similar incident doesn,t occur again. Last month, as ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The ... Supplements, Specialty Nutrients, Animal Feed), Applications (Regular, Therapeutic, ... - Global Trends & Forecasts to 2019 ” ... an analysis and forecasting of the market value ... identifies the driving and restraining factors for the ...
(Date:7/11/2014)... to a new market research report “Internet of Things ... Bluetooth, Wi-Fi, NFC, RFID), Application Vertical (Building Automation, Consumer, ... - Global Trends & Forecasts to 2014 - 2020”, ... $1029.5 Billion in 2013, and is expected to reach ... 4.08% from 2014 to 2020. , Browse more ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Biostimulants are ... growth in turf and ornamentals. These also help turf ... improve length of roots. Turf, ornamentals, and flowers appear ... Therefore, this usage has increased from the last few ... turf and ornamentals is Europe, with around 40% share ...
Breaking Medicine News(10 mins):Health News:Brains of Sex Addicts May Be Wired Like Those of Drug Addicts, Study Finds 2Health News:CDC Issues Tough Report on Anthrax Scare 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3
(Date:7/10/2014)... other major cities in New Mexico, nearly every public ... rather than precious potable water supplies. Across the U.S. ... golf courses receive treated effluent. Reusing the effluent increases ... courses and homeowners alike fertilize their lawns during the ... A New Mexico State University turfgrass expert has a ...
(Date:7/10/2014)... YORK , June 27, 2014  Pomerantz ... Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) ... filed in United States District Court, Middle District ... is on behalf of a class consisting of ... acquired Provectus securities between December 17, 2013 and ...
(Date:7/10/2014)... SPRINGS, Florida , July 1, 2014 ... wallets pave way for convenience and improved security: NXT-ID, Inc. ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... and MasterCard Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: NXTD) ... is pleased to announce that the second series of 30 ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5
Other Contents